Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 9,640 shares of Cardlytics stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $4.39, for a total transaction of $42,319.60. Following the sale, the chief executive officer owned 113,850 shares of the company’s stock, valued at approximately $499,801.50. The trade was a 7.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Amit Gupta also recently made the following trade(s):
- On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total transaction of $28,526.22.
Cardlytics Stock Performance
Shares of Cardlytics stock traded down $0.10 during trading on Monday, hitting $4.37. 58,856 shares of the company’s stock were exchanged, compared to its average volume of 103,822. The business has a 50-day simple moving average of $6.37 and a 200-day simple moving average of $8.75. Cardlytics, Inc. has a 52-week low of $4.25 and a 52-week high of $32.80. The stock has a market capitalization of $25.39 million, a price-to-earnings ratio of -0.25 and a beta of 0.61.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on CDLX
Hedge Funds Weigh In On Cardlytics
A number of large investors have recently bought and sold shares of the business. Renaissance Technologies LLC grew its holdings in Cardlytics by 108.3% in the first quarter. Renaissance Technologies LLC now owns 112,500 shares of the company’s stock valued at $118,000 after purchasing an additional 58,500 shares during the period. Virtu Financial LLC purchased a new position in shares of Cardlytics during the 4th quarter valued at approximately $39,000. Invesco Ltd. lifted its position in shares of Cardlytics by 38.1% during the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after buying an additional 46,973 shares in the last quarter. Barclays PLC grew its stake in Cardlytics by 31,167.6% in the 4th quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after acquiring an additional 55,790 shares during the period. Finally, Goldman Sachs Group Inc. grew its stake in Cardlytics by 15.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after acquiring an additional 14,273 shares during the period. Institutional investors and hedge funds own 68.10% of the company’s stock.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
See Also
- Five stocks we like better than Cardlytics
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
- KBR Insiders Are Buying While the Market Misreads Its Spinoff
- Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
